tiprankstipranks
Advertisement
Advertisement
BriaCell receives FDA clearance to initiate Bria-BRES+ trial
PremiumThe FlyBriaCell receives FDA clearance to initiate Bria-BRES+ trial
1M ago
BriaCell presents anti-cancer activity of Bria-OTS
Premium
The Fly
BriaCell presents anti-cancer activity of Bria-OTS
2M ago
BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR
Premium
The Fly
BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR
2M ago
BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting
PremiumCompany AnnouncementsBriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting
3M ago
BriaCell Restructures Soluble CD80 Program via BriaPro Deal
Premium
Company Announcements
BriaCell Restructures Soluble CD80 Program via BriaPro Deal
4M ago
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
Premium
Company Announcements
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
4M ago
BriaCell says patient images show regression, resolution of metastsized tumors
PremiumThe FlyBriaCell says patient images show regression, resolution of metastsized tumors
4M ago
BriaCell Reports Prolonged Survival in Phase 2 Metastatic Breast Cancer Trial
Premium
Company Announcements
BriaCell Reports Prolonged Survival in Phase 2 Metastatic Breast Cancer Trial
4M ago
BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer
Premium
The Fly
BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100